Ionis Pharmaceuticals

IONSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.462 B

$44.90 +1.03%

Close of 21 Sept 2026

Revenue

$943.7M

#1560 by revenue

Earnings

-$381.4M

Loss-making

Shares outstanding

166,184,322

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#40Praxis Precision MedicinesPRAX$8.34B
#41Spyre TherapeuticsSYRE$8.11B
#42Ionis PharmaceuticalsIONS$7.46B
#43AlkermesALKS$7.41B
#44Amneal PharmaceuticalsAMRX$7.02B

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Ionis Pharmaceuticals, worth $1.06M. Grants and option exercises are excluded.

Michael R. Hayden$1.06M
20,000 shares at $52.94 on 30 Jul 2026 · filed 31 Jul 2026

What if Ionis Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$182,171.54

Per share 4,057× higher

Bitcoin $1.72T

$10,348.77

Per share 230× higher

Nvidia $5.48T

$32,974.58

Per share 734× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Ionis Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.